Clinical Trial Update: Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study [NA]

View source ↗

Summary

Update on the EXCIPSY trial evaluating transcranial magnetic stimulation as a marker of antidepressant response in Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Centre Hospitalier du Rouvray | Conditions: Major Depressive Disorder | NA | Status: UNKNOWN